Companies › Aduro BioTech

Aduro BioTech

Healthcare 📍 Berkeley, United States 👥 11-50 employees 💰 $343.4M raised 📅 Founded 2000

Aduro is a clinical-stage cancer immunotherapy company with three products currently in human trials. The company’s lead candidate – an immunotherapy regimen combining their proprietary CRS-207 with GVAX Pancreas – is targeting metastatic pancreatic cancer and has received Breakthrough Therapy designation from the US F

📊 Company Overview

Sector
Healthcare
Country
United States
Employees
11-50
Total Raised · Seed
$343.4M
Founded
2000
Cloud
AWS
CDN
Cloudflare
Email
Microsoft 365

☁️ Cloud Infrastructure

AWS Detected Cloud Provider

Detected via HTTP headers

WorkspaceMicrosoft 365
CDNCloudflare

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$108K $270K / year on AWS

🛠 Tech Stack & Marketing

Ad Platforms🔒 Subscribers only
Analytics & CRM🔒 Subscribers only
CMS / PlatformWordPress
Frontend Stack🔒 Subscribers only

Detected from Aduro BioTech's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

Data detected 2026-06-13 · Methodology · Suggest a correction